|
Market Cap (4-Jun) $16,057,089 (1,586th) |
Close (30-Jun) $0.375 |
Volume (30-Jun) 3,448 |
Shortsold (16-Aug) 1,155 (0.00%) (595th) |
|
52w High $0.79 |
52w Low $0.110 |
P/E - |
EPS -0.08 |
AGN released this announcement to the ASX on 30 September 2021, 9:52. The announcement is marked as price sensitive, and is 3 page(s) in length and 263.09kb in size.
You can view all announcements from AGN and see how they appear on a price chart on the announcements page.
At the date of this announcement, AGN was 0.000% short sold according to ASIC data. It was ranked the 653rd most shorted stock on the ASX. It is now ranked as the 595th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (16 August 2024).
| Other Recent Announcements from AGN | |
|---|---|
| ARG-007 Protects Brain Cells in Moderate TBI Model | 22 June 2023, 8:19 |
| Becoming a substantial holder | 20 June 2023, 8:21 |
| Becoming a substantial holder | 13 June 2023, 17:34 |
| Argenica Partners With Linear For Phase 1 Clinical Trial | 30 September 2021, 9:52 |
| Date of AGM & Closing Date for Director Nominations | 21 September 2021, 17:15 |
| Argenica Achieves Manufacturing Milestones | 14 September 2021, 9:06 |
| Appendix 4G & Corporate Governance Statement | 27 August 2021, 9:38 |
You must be logged in to post a reply.
